BTG was founded in the beginning of the genetic engineering revolution, when scientists could only dream of producing mammalian proteins in bacterial cells. In July 2005, the Swiss based Ferring group acquired the company along with several of the therapeutic protein products BTG had successfully produced.
BTG is a pioneer in the development and manufacture of human health care products derived from genetic engineering and biotechnology processes, and has a successful track record of developing and registered biopharmaceuticals.
BTG’s Beer Tuvia site houses all company functions, including a state-of-the-art cGMP biologics manufacturing facility; ~300 employees are currently employed.
Broad R&D capabilities and experience
Significant biologics manufacturing experience
An experienced and highly-motivated management team